New guidelines on treating hypertension in diabetics

The mechanism of ceftazidime degradation in aqueous solutions.

Acta poloniae pharmaceutica·1998

The influence of carbohydrates and polyhydric alcohols on the stability of ceftazidime in aqueous solution.

Acta poloniae pharmaceutica·1995

Kinetics of hydrolysis of ceftazidime in aqueous solutions.

Acta poloniae pharmaceutica·1995

Nausea and Vomiting During Pregnancy.

American family physician·2026

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026

Recurrent UTI in Women: Diagnosis and Management.

American family physician·2026

Gambling Disorder: Diagnosis and Treatment.

American family physician·2026

Pacemaker Therapy: Indications and Recommendations.

American family physician·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

New guidelines on treating hypertension in diabetics

Related Concept Videos

The mechanism of ceftazidime degradation in aqueous solutions.

The influence of carbohydrates and polyhydric alcohols on the stability of ceftazidime in aqueous solution.

Kinetics of hydrolysis of ceftazidime in aqueous solutions.

Nausea and Vomiting During Pregnancy.

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

Type 2 Diabetes: Outpatient Insulin Management.

Recurrent UTI in Women: Diagnosis and Management.

Gambling Disorder: Diagnosis and Treatment.

Pacemaker Therapy: Indications and Recommendations.

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

New guidelines on treating hypertension in diabetics

Related Concept Videos

Related Articles